Chaperone signalling complexes in Alzheimer's disease
- PMID: 19449461
- PMCID: PMC2749087
- DOI: 10.1111/j.1582-4934.2008.00557.x
Chaperone signalling complexes in Alzheimer's disease
Abstract
Molecular chaperones and heat shock proteins (Hsp) have emerged as critical regulators of proteins associated with neurodegenerative disease pathologies. The very nature of the chaperone system, which is to maintain protein quality control, means that most nascent proteins come in contact with chaperone proteins. Thus, amyloid precursor protein (APP), members of the gamma-secretase complex (presenilin 1 [PS1] collectively), the microtubule-associated protein tau (MAPT) as well as a number of neuroinflammatory components are all in contact with chaperones from the moment of their production. Chaperones are often grouped together as one machine presenting abnormal or mutant proteins to the proteasome for degradation, but this is not at all the case. In fact, the chaperone family consists of more than 100 proteins in mammalian cells, and the primary role for most of these proteins is to protect clients following synthesis and during stress; only as a last resort do they facilitate protein degradation. To the best of our current knowledge, the chaperone system in eukaryotic cells revolves around the ATPase activities of Hsp70 and Hsp90, the two primary chaperone scaffolds. Other chaperones and co-chaperones manipulate the ATPase activities of Hsp70 and Hsp90, facilitating either folding of the client or its degradation. In the case of Alzheimer's disease (AD), a number of studies have recently emerged describing the impact that these chaperones have on the proteotoxic effects of tau and amyloid- beta accumulation. Here, we present the current understandings of chaperone biology and examine the literature investigating these proteins in the context of AD.
Figures



Similar articles
-
Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.Prog Neurobiol. 2011 Jan;93(1):99-110. doi: 10.1016/j.pneurobio.2010.10.006. Epub 2010 Nov 5. Prog Neurobiol. 2011. PMID: 21056617 Review.
-
HSP70-HSP90 Chaperone Networking in Protein-Misfolding Disease.Subcell Biochem. 2023;101:389-425. doi: 10.1007/978-3-031-14740-1_13. Subcell Biochem. 2023. PMID: 36520314 Review.
-
Chaperones-A New Class of Potential Therapeutic Targets in Alzheimer's Disease.Int J Mol Sci. 2024 Mar 17;25(6):3401. doi: 10.3390/ijms25063401. Int J Mol Sci. 2024. PMID: 38542375 Free PMC article. Review.
-
Targeting Chaperone/Co-Chaperone Interactions with Small Molecules: A Novel Approach to Tackle Neurodegenerative Diseases.Cells. 2021 Sep 29;10(10):2596. doi: 10.3390/cells10102596. Cells. 2021. PMID: 34685574 Free PMC article. Review.
-
Alzheimer's Disease and Molecular Chaperones: Current Knowledge and the Future of Chaperonotherapy.Curr Pharm Des. 2016;22(26):4040-9. doi: 10.2174/1381612822666160518141437. Curr Pharm Des. 2016. PMID: 27189602 Review.
Cited by
-
Patient-Derived Fibroblasts With Presenilin-1 Mutations, That Model Aspects of Alzheimer's Disease Pathology, Constitute a Potential Object for Early Diagnosis.Front Aging Neurosci. 2022 Jul 1;14:921573. doi: 10.3389/fnagi.2022.921573. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35847683 Free PMC article.
-
Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies.Future Med Chem. 2011 Sep;3(12):1523-37. doi: 10.4155/fmc.11.88. Future Med Chem. 2011. PMID: 21882945 Free PMC article. Review.
-
A Polymorphism in the Gene Encoding Heat Shock Factor 1 (HSF1) Increases the Risk of Type 2 Diabetes: A Pilot Study Supports a Role for Impaired Protein Folding in Disease Pathogenesis.Life (Basel). 2022 Nov 20;12(11):1936. doi: 10.3390/life12111936. Life (Basel). 2022. PMID: 36431071 Free PMC article.
-
PARP overactivation in neurological disorders.Mol Biol Rep. 2021 Mar;48(3):2833-2841. doi: 10.1007/s11033-021-06285-1. Epub 2021 Mar 25. Mol Biol Rep. 2021. PMID: 33768369 Review.
-
Relationship of Muscle Apolipoprotein E Expression with Markers of Cellular Stress, Metabolism, and Blood Biomarkers in Cognitively Healthy and Impaired Older Adults.J Alzheimers Dis. 2023;92(3):1027-1035. doi: 10.3233/JAD-221192. J Alzheimers Dis. 2023. PMID: 36847010 Free PMC article.
References
-
- Mullan M, Houlden H, Windelspecht M, Fidani L, Lombardi C, Diaz P, Rossor M, Crook R, Hardy J, Duff K, Crawford F. A locus for familial early-onset Alzheimer's disease on the long arm of chromosome 14, proximal to the alpha 1-antichy-motrypsin gene. Nat Genet. 1992;2:340–2. - PubMed
-
- Van Broeckhoven C, Haan J, Bakker E, Hardy JA, Van Hul W, Wehnert A, Vegter-Van der Vlis M, Roos RA. Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch) Science. 1990;248:1120–2. - PubMed
-
- Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991;349:704–6. - PubMed
-
- Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, Mullan M. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature. 1991;353:844–6. - PubMed
-
- Campion D, Flaman JM, Brice A, Hannequin D, Dubois B, Martin C, Moreau V, Charbonnier F, Didierjean O, Tardieu S, Penet C, Puel M, Pasquier F, Le Doze F, Bellis G, Calenda A, Heiolig R, Martinez M, Mallet J, Bellis M, Clerget-Darpoux F, Agid Y, Trebourg T. Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Hum Mol Genet. 1995;4:2373–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical